TNF and rheumatoid arthritis: The aim of this study was to determine whether the risk of CVEs in patients with RA, AS or PsA was associated with treatment with anti-TNF therapy, compared with other biologics or non-biologic therapy, and to compare the CVE risk between arthritis diagnoses.